Acta Med. 2003, 46: 131-137
https://doi.org/10.14712/18059694.2019.22
Control of T Cell Responses, Tolerance and Autoimmunity by Regulatory T Cells: Current Concepts
References
1. O, Freeman GJ, Meyer EH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8:1024–32.
<https://doi.org/10.1038/nm745>
2. AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2Rα and IL-2 shape a population of regulatory cells that controls CD4+ T-cell numbers. J Immunol 2002; 169:4850–60.
<https://doi.org/10.4049/jimmunol.169.9.4850>
3. M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J Exp Med 1996; 184:387–96.
<https://doi.org/10.1084/jem.184.2.387>
<PubMed>
4. FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10–producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2–inducing cytokines. J Exp Med 2002; 195:603–16.
<https://doi.org/10.1084/jem.20011629>
<PubMed>
5. JF. Immunotherapy of insulin-dependent diabetes mellitus. Curr Opin Immunol 2001; 13(5):601–5.
<https://doi.org/10.1016/S0952-7915(00)00267-3>
6. JF. Regulatory T cells unde Scrutiny. Nature Rev Immunol 2003; 3:189–98.
<https://doi.org/10.1038/nri1026>
7. T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med 2003; 197(4):451–60.
<https://doi.org/10.1084/jem.20021387>
<PubMed>
8. M, Bluestone JA, Barriot S,Megret J, Bach JF, Chatenoud L. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nature Med 2003; 9:1202–8.
<https://doi.org/10.1038/nm924>
9. Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502–7.
<https://doi.org/10.1038/nature01152>
10. SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM. Major histocompatibility complex class-II-positive cortical epithelium mediates the selection of CD4+CD25+ immunoregulatory T cells. J Exp Med 2001; 194:427–38.
<https://doi.org/10.1084/jem.194.4.427>
<PubMed>
11. JA, Abbas AK. Natural versus adaptive regulatory T cells. Nature Rev Immunol 2003; 3:253–7.
<https://doi.org/10.1038/nri1032>
12. C, Yasunami R, Dardenne M, Bach JF. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989; 169(5):1669–80.
<https://doi.org/10.1084/jem.169.5.1669>
<PubMed>
13. A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995; 25(9): 2643–96.
<https://doi.org/10.1002/eji.1830250936>
14. JG, Bartok I, Chandler P et al. Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999; 29:686–92.
<https://doi.org/10.1002/(SICI)1521-4141(199902)29:02<686::AID-IMMU686>3.0.CO;2-N>
15. L, Lefevre H, Thivolet C et al. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomized controlled trial. Diabete Insuline Orale group. Lancet 2000; 356:545–9.
<https://doi.org/10.1016/S0140-6736(00)02579-4>
16. L. CD-3 specific antibody-induced active tolerance: from bench to bedside. Nature Rev Immunol 2003; 3:123–32.
<https://doi.org/10.1038/nri1000>
17. C, Lee WH, Yun P, Snow P, Liu CP. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 2003; 171(2):733–44.
<https://doi.org/10.4049/jimmunol.171.2.733>
18. F, Hurst SD, Coffman RL, Groux H. T regulatory cells 1 inhibit a Th2–specific response in vivo. J Immunol 2000; 165:4848–53.
19. JD, Leong LY, Mellor A, Cobbold SP, Waldmann H. T-cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602–7.
20. D, Bruett CH, Ploettner H, Luty MB, Schuler G. Human CD4+ CD25+ regulatory, contact-dependent T cells induce interleukin-10–producing, contact-independent type-1–like regulatory T cells. J Exp Med 2002; 196:247–53.
<https://doi.org/10.1084/jem.20020642>
<PubMed>
21. AM, Weiner HL. Oral tolerance: mechanisms and therapeutic applications. Adv Immunol 1999; 73:153–264.
<https://doi.org/10.1016/S0065-2776(08)60787-7>
22. D, Mason D. Evidence that the T-cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization CD4+ T-cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177:627–36.
<https://doi.org/10.1084/jem.177.3.627>
<PubMed>
23. H, Ruiz PJ,Watkins TA et al. Combination of gene delivery and D N A vaccination to protect from and reverse TH1 autoimmune disease via deviation to the TH2 pathway. Immunity 2001; 15:15–22.
<https://doi.org/10.1016/S1074-7613(01)00171-6>
24. MA, Clarke SR, Negrou A, Gallegos A, Rudensky A. Homeostasis and anergy of CD4+ CD25+ suppressor T cells in vivo. Nat Immunol 2002; 3:33–41.
<https://doi.org/10.1038/ni743>
25. RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970; 18:723–37.
26. A, Andre-Schmutz I, Camaud C, Mathis D, Benoist C. Damage control, rather than unresponsivenss, effected by protective DX5+ T cells in autoimmune diabetes. Nat Immunol 2001; 2:1117–25.
<https://doi.org/10.1038/ni738>
27. H. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003; 75(Suppl. 9):8S-12S.
<https://doi.org/10.1097/01.TP.0000067944.90241.BD>
28. H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737–42.
<https://doi.org/10.1038/39614>
29. A, Martinez NR, Davey GM, Heath WR, Harrison LC. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J Clin Invest 2002; 109:261–7.
<https://doi.org/10.1172/JCI0213720>
30. KC, Hagopian W, Auger JA et al. Anti-CD3 monoclonal antibody in newonset type 1 diabetes mellitus. N Engl J Med 2002; 346:1692–8.
<https://doi.org/10.1056/NEJMoa012864>
31. D, Holtz A, Bot A et al. Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 1999:11(4):463–72.
<https://doi.org/10.1016/S1074-7613(00)80121-1>
32. M, Messer RJ, Peterson KE, Strommes IM, Sugie T, Hasenkrug KJ. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci USA 2001; 98:9226–30.
<https://doi.org/10.1073/pnas.151174198>
<PubMed>
33. H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10 producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192:1213–22.
<https://doi.org/10.1084/jem.192.9.1213>
<PubMed>
34. K, Gjata B, Danos O, von Boehmer H, Sarukhan A. Regulatory function of in vivo anergized CD4+ T cells. Proc Natl Acad Sci USA. 2001; 98:8738–43.
<https://doi.org/10.1073/pnas.151088898>
<PubMed>
35. C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421(6921):388–92.
<https://doi.org/10.1038/nature01315>
36. S, Scherberg N, DeGroot LJ. Induction of oral tolerance in human autoimmune thyroid disease. Thyroid 1998; 8:229–34.
<https://doi.org/10.1089/thy.1998.8.229>
37. F, Gagnerault MC. Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 2000; 164(1): 240–7.
<https://doi.org/10.4049/jimmunol.164.1.240>
38. A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003; 4:350–4.
<https://doi.org/10.1038/ni906>
39. G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in-vitro. Science 1994; 264:1587–9.
<https://doi.org/10.1126/science.8202711>
40. LT, Maricic I, Sercary E, Kumar V. Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J Immunol 2003; 170(6):2985–92.
<https://doi.org/10.4049/jimmunol.170.6.2985>
41. TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ−deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002; 17:167–78.
<https://doi.org/10.1016/S1074-7613(02)00367-9>
42. NA, Vickers MA, Barker RN. Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. J Immunol 2003; 170:6183–9.
<https://doi.org/10.4049/jimmunol.170.12.6183>
43. B, Wraith DC. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 1993; 5:1159–65.
<https://doi.org/10.1093/intimm/5.9.1159>
44. P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195:221–31.
<https://doi.org/10.1084/jem.20011288>
<PubMed>
45. P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectiozus diseases. Trends Immunol 2002; 23(9):450–5.
<https://doi.org/10.1016/S1471-4906(02)02288-3>
46. Y, Sakakura T. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969; 166:753–5.
<https://doi.org/10.1126/science.166.3906.753>
47. Poudrier J, Weng X, Kay DG, Hanna Z, Jolicoeur P. The AIDS-like disease of CD4C/HIV Tg mice is associated with accumulation of immature CD11bHi dendritic cells. J Virol (In Press).
48. F. Foxp3 and Natural Regulatory T Cells: Key to a Cell Lineage? Immunity 2003; 19:165–8.
<https://doi.org/10.1016/S1074-7613(03)00207-3>
49. S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains. J Immunol 1995; 155:1151–64.
50. RH. T Cell Anergy. Ann Rev Immunol 2003; 21:305–34.
<https://doi.org/10.1146/annurev.immunol.21.120601.141110>
51. A, Copie-Bergman C, Hashim G et al. Healthy monozygous twins do not recognize identical T-cell epitopes on the myelin basic protein autoantigen. Eur J Immunol 1994; 24:2299–303.
<https://doi.org/10.1002/eji.1830241006>
52. B, Mason D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor -β and interleukin-4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4+CD45RC-cells and CD4+CD8–thymocytes. J Exp Med 1999; 189:279–88.
<https://doi.org/10.1084/jem.189.2.279>
<PubMed>
53. B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T cells. Immunol Review 2001; 182:190–200.
<https://doi.org/10.1034/j.1600-065X.2001.1820115.x>
54. GL, Ignatowicz L. Decreasing the threshold for thymocyte activation biases CD4+ T cells toward a regulatory (CD4+ CD25+) lineage. Eur J Immunol 2003; 33(5):1282–92.
<https://doi.org/10.1002/eji.200323927>
55. C, Barber DL, Chiodetti L, Schwartz RH. Adaptive tolerance of CD4+ T cells in vivo: multiple thresholds in response to a constant level of antigen presentation. J Immunol 2001; 167:2030–9.
<https://doi.org/10.4049/jimmunol.167.4.2030>
56. T, Reddy P, Liu C, Williams D, Cooke KR, Ferrara JLM. Impaired thymic negative selection causes autoimmune graft- versus-host disease. Blood 2003; 102:429–35.
<https://doi.org/10.1182/blood-2003-01-0266>
57. AM, Shevach EM. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287–96.
<https://doi.org/10.1084/jem.188.2.287>
<PubMed>
58. KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25+ CD4+ T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167:188–95.
<https://doi.org/10.4049/jimmunol.167.1.188>
59. SR, Diedrichs-Mohring M, Fricke H, Arbogast S, Wildner G. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis patients with an MHC-peptide crossreactive with autoantigen-first results. Immunol Lett 1997; 57:193–201.
<https://doi.org/10.1016/S0165-2478(97)00058-8>
60. DE, Dynesius-Trentham RA, Orav EJ et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261(5129): 1727–30.
<https://doi.org/10.1126/science.8378772>
61. Jl, Mowat AM, O’Malley JM, Williamson E, Fanger NA. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J Immunol 1998; 160(12):5815–25.
62. MG, Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nature Rev Immunol 2003; 3:223–32.
<https://doi.org/10.1038/nri1029>
63. A, Fournier N, Brun V, Breittmayer JP, Cortez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18:605–17.
<https://doi.org/10.1016/S1074-7613(03)00113-4>
64. HL. Induction and mechanism of action of transforming growth factorbeta- secreting Th3 regulatory cells. Immunol Rev 2001; 182:207–14.
<https://doi.org/10.1034/j.1600-065X.2001.1820117.x>
65. HL. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2001; 2(8):671–2.
<https://doi.org/10.1038/90604>
66. HL, Friedman A, Miller A et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12:809–37.
<https://doi.org/10.1146/annurev.iy.12.040194.004113>
67. HL, Mackin GA, Matsui M et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259(5099):1321–4.
<https://doi.org/10.1126/science.7680493>
68. S, Iyoda T, Tarbell K et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003; 198(2):235–47.
<https://doi.org/10.1084/jem.20030422>
<PubMed>
69. ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88(22):10252–6.
<https://doi.org/10.1073/pnas.88.22.10252>
<PubMed>
70. SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25–precursors. J Immunol 2002; 169(8):4183–9.
<https://doi.org/10.4049/jimmunol.169.8.4183>
